Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

December 9, 2015December 9, 2015

Mesothelioma Specialists Focus on Merck’s Lung Cancer Drug Keytruda

News

The recently FDA-approved cancer drug Keytruda (pembrolizumab), for the treatment of for non-small cell lung cancer (NSCLC), has prompted investigators in Toronto, Canada to release a report with an outline of the ... Read more

December 4, 2015December 4, 2015

WT1 Vaccine Aids Mesothelioma Patients’ Survival in Phase 2 Trial

News

SELLAS Life Sciences Group, a biopharmaceutical company working to develop novel drugs to treat cancer and central nervous system (CNS) conditions, recently announced top-line results from the Phase 2 trial of its ... Read more

December 2, 2015December 21, 2015

For Malignant Pleural Mesothelioma, a Therapeutic Route Is Underway

News

In a recent study published in the journal Annals of Translational Medicine, Andrea Viti and colleagues from the Thoracic Surgery Unit, Sacro Cuore-Don Calabria Research Hospital, in Italy, discussed the ... Read more